WEEKS DOYLE C 4
4 · AVOCENT CORP · Filed Feb 3, 2005
Insider Transaction Report
Form 4
AVOCENT CORPAVCT
WEEKS DOYLE C
DirectorPresident, COO
Transactions
- Exercise/Conversion
Common Stock
2005-02-01$22.36/sh+50,000$1,118,000→ 51,176 total - Sale
Common Stock
2005-02-01$36.78/sh−50,000$1,839,000→ 1,176 total - Exercise/Conversion
Options (rights to buy)
2005-02-01−50,000→ 0 totalExercise: $22.36From: 2001-05-25Exp: 2011-05-25→ Common stock (50,000 underlying) - Purchase
Common Stock
2005-02-01$22.95/sh+204$4,682→ 1,380 total
Holdings
- 200,000
Options (rights to buy)
Exercise: $52.44From: 2000-09-18Exp: 2010-09-18→ Common Stock (200,000 underlying) - 15,000
Options (rights to buy)
Exercise: $21.77From: 2002-04-15Exp: 2012-04-15→ Common Stock (35,000 underlying) - 40,000
Options (rights to buy)
Exercise: $40.98From: 2004-02-05Exp: 2014-02-05→ Common Stock (40,000 underlying) - 25,000
Options (rights to buy)
Exercise: $26.94From: 2000-05-02Exp: 2010-05-02→ Common stock (25,000 underlying) - 100,000
Options (rights to buy)
Exercise: $27.25From: 2003-03-07Exp: 2013-03-07→ Common Stock (100,000 underlying)
Footnotes (4)
- [F1]Grant date, 50% vest and become exercisable on the first anniversary of the grant date and 25% on each grant date anniversary thereafter.
- [F2]Grant date, 15% vests every six months for the first 12 months, 6.25% vests quarterly for the following 24 months and 5% vests quarterly for the remaining 12 months.
- [F3]Grant date, 25% vests after 6 months and in 10 equal quarterly installments thereafter.
- [F4]Shares purchased under the Avocent Corporation employee stock purchase plan.